MDMA‐assisted psychotherapy reduces PTSD symptom severity
Mental Health Weekly February 15, 2021 DOI: 10.1002/mhw.32682 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | MDMA Psychedelic-assisted therapy PTSD |
| Key points | Prior use of SSRIs may reduce the effectiveness of MDMA-assisted therapy for PTSD. |
Abstract
Prior use of selective serotonin reuptake inhibitors (SSRIs) may reduce the effectiveness of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted therapy for post‐traumatic stress disorder (PTSD), say researchers of a recent study who noted that MDMA is close to being considered the first psychedelic drug approved to treat PTSD.